SEC Tracker
Get the app

Celcuity CELC

Celcuity (CELC) has filed its Q3 2025 Form 10-Q, providing investors with an update on the company's quarterly financial performance and operational activities. The filing highlights Celcuity's progress in advancing its cancer diagnostic platform and pipeline, which is critical for assessing the company's near-term growth prospects and competitive positioning within the healthcare technology sector.

Form
10-Q
Filed
Importance
Notable

Open in the appGet the appView on EDGAR

Get an email when Celcuity files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. Fortrea Holdings FTRE public float $448M, Jun 30, 2025
  2. Castle Biosciences CSTL public float $576M, Jun 30, 2025
  3. Personalis PSNL public float $578M, Jun 30, 2025
  4. Fulgent Genetics FLGT public float $284M, Jun 30, 2025
  5. CareDx CDNA public float $1.0B, Jun 30, 2025